Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2002 / Cilt: 36 - Sayı: 1

The evaluation of class I and class II HLA antigens in patients with chronic idiopathic urticaria

Kronik idiyopatik ürtikerli hastalarda sınıf I ve sınıf II HLA antijenlerinin incelenmesi

Pages
34–39
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: We assume that the presence of antigens HLA DR13 could increase the incidence of CIU and play a role in its pathogenesis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: Chronic idiopathic urticaria (CIU) is a common disease of which pathogenesis is unclear and resistant to therapy.
📊
Key Findings & Data:Materials and Methods: HLA Class I and Class II antigens were investigated in 55 patients diagnosed as CIU, utilizing two stage microlymphocytotoxicity test.
💡
Conclusion & Impact:Conclusion: We assume that the presence of antigens HLA DR13 could increase the incidence of CIU and play a role in its pathogenesis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and Design: Chronic idiopathic urticaria (CIU) is a common disease of which pathogenesis is unclear and resistant to therapy. Recent investigations have indicated that autoimmunity plays role in nearly one third of CIU patients. The present study aimed to investigate the relationship between HLA Class I and Class II antigens and immune pathogenesis of CIU. Materials and Methods: HLA Class I and Class II antigens were investigated in 55 patients diagnosed as CIU, utilizing two stage microlymphocytotoxicity test. Seventy one healty and genetically unrelated individuals were evaluated as control group. Results: While significant differences were not found between patient and control groups in all HLA Class I antigens and DQ focuses of Class II HLA antigens, HLA DR13 antigens were statistically high in patient group( p=0.03). Conclusion: We assume that the presence of antigens HLA DR13 could increase the incidence of CIU and play a role in its pathogenesis.

Özet

Kronik idiyopatik ürtiker (KİU) sık rastlanan ve tedaviye dirençli patogenezi henüz tam anlaşılamamış bir hastalıktır. Son yıllarda konu ile ilgili yapılan çalışmalarda KİU olgularının üçte birinde patogenezde otoimmunitenin rol oynadığı gösterilmiştir. Bu çalışmada KİU patogenezinde HLA Sınıf l ve Sınıf II antijenleri ile ilişkisinin gösterilmesi amaçlandı. Çalışmada KİU tanısı konulan 55 hastada HLA Sınıf l (ABC) ve HLA Sınıf II (DQ,DR) antijenleri, iki adımlı mikrolenfositotoksisite testi ile araştırıldı. Sağlıklı ve akrabalık ilişkisi olmayan 71 kişi kontrol grubu olarak değerlendirildi. HLA Sınıf l antijenlerinin tamamında ve HLA Sınıf II antijen grubunda DQ lokusunda iki grup arasında istatistiksel olarak anlamlı farklılık yokken, HLA-DR13 antijen sıklığında hasta grubunda artış saptandı( p=0.03). HLA-DR13 antijen varlığının kronik idiyopatik ürtiker riskini arttırabileceği ve patogenezde rol oynayabileceği düşünüldü.

🔖

Cite This Article

AYDOĞAN, K., BAŞKAN, B. E., TUNALI, Ş. (2022). The evaluation of class I and class II HLA antigens in patients with chronic idiopathic urticaria. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 36 - Sayı: 1, 34–39. https://ajindex.com/articles/622255

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Graves MW:Chronic urticaria. J Allergy Clin Immunol 2000
  2. 672 2. Juhlin L: Incidence of intolerance to food additives Int J Derma- tol 1980
  3. 551 3. Hellgren L: The prevalance of urticaria in the total population. Acta Allerologica 1972
  4. 240 4. Juhlin L: Recurrent urticaria: clinical investigation of 330 pati- ents. Br J Dermatol 1981
  5. 381 5. Sibbald RG, Cheema AS, Lozinski A, Tarlo S: Chronic urticaria: evaluation of the role of physical, immunologic, and other contri- butory factors. Int J Dermatol 1991
  6. 386 6. Sabroe RA, Seed PT, Francis DM, Barr RM, Black AK, Greaves MW: Chronic idiopathic urticaria: comparison of the clinical fe- atures of patients with and without anti-Fc_RI or anti-lgE auto- antibodies. J Am Acad Dermatol 1999
  7. 450 7. Krause LB, Shuster S: H1-receptor-active histamine not sole cause of chronic idiopathic urticaria. Lancet 1984
  8. 930 8. Jorizzo JL, Smith EB: The physical urticarias: an update and re- view. Arch Dermatol 1982
  9. 201 9. Barlow RJ, Warburton F, Watson K Black AK, Greaves MW: Di- agnosis and incidence of delayed pressure urticaria in patients with chronic urticaria. J Am Acad Dermatol 1993
  10. 958 10. Leung DYM, Diaz LA, DeLeo V, Soter NA: Allergic and immu- nologic skin disorders. JAMA 1997
  11. 1923 11. Grattan CEH, Wallington TB, Warin RP, Kennedy CTL, Bradfi- eld JW: A serological mediator in chronic idiopathic urticaria: a clinical, immunological and histological evaluation. Br J Derma-toll 986
  12. 590 12. Gruber BL, Thaeza ML, Marchase MJ, Aquello V, Kaplan AP: Prevalance and functional role of anti-lgE autoantibodies in urti- carial syndromes. J Invest Dermatol 1988
  13. 21 7 13. Grattan CEH, Francis DM, Hide M, Greaves MW: Detection of circulating histamine releasing autoantibodies with functional properties of anti-lgE in chronic urticaria. Clin Exp Allergy 1991
  14. 704 14. Hide M, Francis DM, Grattan CEH, Greaves MW: Autoantibodi- es against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Eng J Med 1993
  15. 1604 15. Fiebiger E, Maurer D, Holub H, Reininger B, Hartmann G, Wo- isetschlager M et al.: Serum IgG autoantibodies directed aga- inst the a chain of Fc_RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J Clin Invest 1995
  16. 2612 16. Niimi N, Francis DM, Kermani F, Greaves MW, Black AK, O'Donnel BF et al.: Dermal mast cell activation by auto